Statistically developed docetaxel-laden mixed micelles for improved therapy of breast cancer
Docetaxel (DTX) has poor solubility, serious side effects, and multi-drug resistance (MDR) limiting its use in cancer treatment. Hence, the present study aimed to formulate and develop docetaxel mixed micelles (DTX MMs) for breast cancer treatment. DTX MMs were prepared from a mixture of docetaxel,...
Main Authors: | Smita S. Patil, Rutuja D. Chougale, Arehalli S. Manjappa, John I. Disouza, Ashok A. Hajare, Kiran S. Patil |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-11-01
|
Series: | OpenNano |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S235295202200041X |
Similar Items
-
Development of docetaxel-loaded (Soluplus®–PF108) mixed micelles vacuum foam-dried product for improved stability and melanoma treatment by QbD approach
by: Rutuja Chougale, et al.
Published: (2024-04-01) -
Design, development, and evaluation of docetaxel-loaded niosomes for the treatment of breast cancer
by: Dipika S. Gaikwad, et al.
Published: (2023-05-01) -
Design and Synthesis of Amphiphilic Graft Polyphosphazene Micelles for Docetaxel Delivery
by: Diana Serbezeanu, et al.
Published: (2023-05-01) -
Comparative Study of TPGS and Soluplus Polymeric Micelles Embedded in Poloxamer 407 In Situ Gels for Intranasal Administration
by: Bence Sipos, et al.
Published: (2024-08-01) -
Enhanced oral bioavailability of magnolol via mixed micelles and nanosuspensions based on Soluplus®-Poloxamer 188
by: Guoyuan Li, et al.
Published: (2020-01-01)